Medicine & Life Sciences
Cytomegalovirus
100%
maribavir
50%
Ganciclovir
40%
Infections
38%
Transplant Recipients
36%
Mutation
35%
Cytomegalovirus Infections
27%
Phosphotransferases
24%
Antiviral Agents
24%
Transplants
23%
HIV
22%
AIC246
22%
Drug Resistance
20%
Pharmaceutical Preparations
20%
Foscarnet
20%
Coronavirus
18%
Veterans
18%
Methicillin-Resistant Staphylococcus aureus
17%
Anti-Bacterial Agents
17%
Therapeutics
16%
DNA-Directed DNA Polymerase
15%
Delivery of Health Care
14%
Veterans Health
14%
United States Department of Veterans Affairs
14%
Hematologic Neoplasms
14%
Viruses
13%
Staphylococcal Infections
13%
Communicable Diseases
13%
Codon
13%
Pre-Exposure Prophylaxis
12%
Cidofovir
12%
Viral Drug Resistance
12%
Outpatients
11%
Vaccines
10%
Quinolones
10%
terminase
10%
Nontuberculous Mycobacteria
10%
Hematopoietic Stem Cells
10%
Vaccination
9%
Toxoplasmosis
9%
Tuberculosis
9%
Incidence
9%
Carbapenem-Resistant Enterobacteriaceae
8%
Organ Transplantation
8%
SARS Virus
8%
Carbapenems
8%
Tenofovir
8%
Neurocysticercosis
8%
Genes
8%
Clinical Trials
8%
Population
8%
Bacterial Infections
8%
Toxoplasma
8%
Pseudomonas aeruginosa
7%
cyclopropavir
7%
Gonorrhea
7%
In Vitro Techniques
7%
Valganciclovir
7%
Pandemics
7%
Pseudomonas Infections
7%
Exonucleases
7%
Hematopoietic Stem Cell Transplantation
7%
Mycobacterium abscessus
7%
Tissue Donors
7%
Invasive Fungal Infections
6%
Epidemiology
6%
Meropenem
6%
Sexual and Gender Minorities
6%
Staphylococcus aureus
6%
Hepacivirus
6%
Bacteremia
6%
Guidelines
6%
dalbavancin
6%
Severe Acute Respiratory Syndrome
6%
isavuconazole
6%
Viral Load
6%
Virus Diseases
5%
Infection Control
5%
Osteomyelitis
5%
Phenotype
5%
DNA
5%
Hepatitis C
5%
Vancomycin
5%
Suppuration
5%
Chlamydia
5%
Fluoroquinolones
5%
Nursing Homes
5%
Respiratory Tract Infections
5%
carbapenemase
5%
methylenecyclopropane
5%
Inpatients
5%
High-Throughput Nucleotide Sequencing
5%
Public Health
5%
Coronavirus Infections
5%
Skin
5%
Safety
5%
Rifampin
5%
Cell Culture Techniques
5%
Substance-Related Disorders
5%